Neuroblastoma has one of the lowest survival rates of all childhood cancers despite the use of intensive treatment regimens usually consisting of a mix of surgery, chemotherapy, radiotherapy, stem cell transplant, immunotherapy and retinoid therapy. However, because...
Radiation therapy, traditionally used to successfully treat many internal cancers, can also provide highly effective—and often superior—therapy for skin cancers. Electron radiation therapy, which uses high-energy rays, is the choice for safe, effective skin cancer...
A novel RADiant system provides a pain free, non-surgical alternative for the treatment of non-melanoma skin cancer and superficial keloid lesions. The Xstrahl (Camberley, United Kingdom) RADiant System is a mobile, compact, ergonomic superficial X-ray therapy...
At the 2017 Annual Meeting of the American Society for Radiation Oncology (ASTRO) researchers announced the development of an efficient and reproducible method to deliver craniospinal irradiation to patient-derived xenograft in mouse models. Despite aggressive...
November 9th, 2017 – Following the supply of an Xstrahl 200 to the Island of Cuba, Xstrahl Medical has reached out to the rest of South America and Spanish speaking countries to solve the ever-present problem of skin cancer. Whilst pale skin is at a higher risk of...
Patients with glioblastoma have poor outcomes due to local relapse despite surgery and high-dose radiotherapy. Resistance to radiotherapy is thought to be due to efficiency of DNA repair cells, such as RAD51, are able to survive DNA damage from radiotherapy and...
Rhabdomyosarcoma (RMS) is the most common soft tissue malignancy in children. Despite intensive research in recent decades the prognosis for patients with metastatic or relapsed diseases has only marginally improved. New therapeutic concepts in anti-tumor therapy aim...
The Xstrahl 100 is perfectly suited for the treatment of non-melanoma skin cancers, and with Australia recording skin cancer rates of 2 in every 3 adults, the need for an effective and versatile treatment method is essential. With the aim to offer non-melanoma skin...
October 17th, 2017 – The new Xstrahl RADiant System has been granted FDA 510(k) clearance for sale in the US. The RADiant System is a compact and ergonomic superficial X-Ray therapy system operating in the 10kV to 80kV range intended for superficial radiotherapy and...